Mayo Clinic Prescription weight-loss drugs Plain-language clinician-reviewed background on GLP-1 medications, common side effects, and when to seek care
The standard retatrutide dose schedule from clinical trials The phase 2 trial published in the New England Journal of Medicine tested multiple dosing arms, and the data from these arms forms the foundation of every retatrutide dose schedule used today
The general principle of escalation observed in the trial involved starting at a low dose and titrating upward at approximately four-weekly intervals, with the highest-dose arm targeting 12 mg once weekly
GLP-1 receptors are also found on different immune cells, such as neutrophils and eosinophils, and their activation has modulatory effects on immune responses and inflammatory processes associated with these types of cells
Sex-dependent divergence in the effects of GLP-1 agonist exendin-4 on alcohol reinforcement and reinstatement in C57BL/6J mice
Symptoms of gallbladder problems including pain in the upper right abdomen, especially after eating fatty foods, warrant investigation
